Sunitinib Malate Capsule
Product Images NDC 0093-8231

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 0093-8231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of the active ingredient Sunitinib Malate, showing its molecular composition including aromatic rings, nitrogen atoms, fluorine atom, and carboxylic acid groups.*

FDA Label Image

1 (Image 2)

A Kaplan-Meier survival curve graph showing time to tumor progression probability (%) over weeks for Sunitinib Malate versus placebo. The graph compares 207 subjects on Sunitinib Malate with a median progression time of 27.3 weeks to 105 placebo subjects with median time of 6.4 weeks, also displaying hazard ratio and confidence interval statistics.*

FDA Label Image

1 (Image 3)

A Kaplan-Meier curve chart showing progression-free survival probability (%) over time in weeks for two treatment groups: Sunitinib Malate and IFN-α, each with 375 subjects. The Sunitinib Malate group has a median survival of 47.3 weeks, while the IFN-α group has a median survival of 22.0 weeks. The chart includes a hazard ratio of 0.42 with a 95% confidence interval of 0.32 to 0.54 and a p-value less than 0.000001. The number of subjects at risk is displayed below the x-axis for both groups at various time points.*

FDA Label Image

1 (Image 4)

A Kaplan-Meier survival curve chart comparing disease-free survival probability over time in years between Sunitinib Malate and placebo groups. The chart shows data for 309 subjects receiving Sunitinib Malate with a median survival of 6.8 years, and 306 placebo subjects with a median survival of 5.6 years. The graph includes hazard ratio and confidence interval data.*

FDA Label Image

1 (Image 5)

A Kaplan-Meier survival curve comparing progression-free survival probability over time (in months) between Sunitinib Malate and placebo groups. The chart includes survival probabilities (%) on the Y-axis and time in months on the X-axis, with separate lines for Sunitinib Malate and placebo, annotated median survival times, hazard ratio, confidence interval, p-value, and number of subjects at risk at various time points.*

FDA Label Image

1 (Image 6)

Label for Sunitinib Malate Capsules 12.5 mg by Teva Pharmaceuticals USA, Inc. The label indicates a prescription drug with 28 capsules per container. It includes storage instructions, dosage caution, and a barcode with serialization coding area. The label highlights dispensing instructions and pharmaceutical details.*

FDA Label Image

1 (Image 7)

Label for Sunitinib Malate Capsules 25 mg by Teva Pharmaceuticals USA, Inc. The label states that each capsule contains 33.4 mg sunitinib malate equivalent to 25 mg sunitinib. The package includes 28 capsules with instructions to dispense with a medication guide. Storage instructions and safety warnings are also visible.*

FDA Label Image

1 (Image 8)

Sunitinib Malate Capsules 37.5 mg oral dosage form by Teva Pharmaceuticals USA, Inc. The label states 28 capsules per container, with dispensing instructions to provide the Medication Guide to each patient. Storage conditions and manufacturer details are included, along with a barcode and NDC number 0093-8229-28.*

FDA Label Image

1 (Image 9)

Label for Sunitinib Malate Capsules 50 mg by Teva Pharmaceuticals USA, Inc. The label indicates 28 capsules per package with oral dosage form. It includes storage instructions, dosage caution, and a barcode along with the NDC number 0093-8231-28. The label features the Teva logo and emphasizes pharmacist dispensing guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.